Avraham Ben-Tzvi - 01 Oct 2025 Form 3 Insider Report for Black Titan Corp (BTTC)

Reporting relationship: Director
Issuer ticker: BTTC
Reported as of: 01 Oct 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 19 Mar 2026, 07:44:30 UTC
Prior SEC filing: 28 Feb 2025
Next SEC filing: 23 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Avraham Ben-Tzvi

Key filing fact

Avraham Ben-Tzvi filed Form 3 for Black Titan Corp (BTTC) on 19 Mar 2026.

Key facts

This page summarizes Avraham Ben-Tzvi's Form 3 filing for Black Titan Corp (BTTC).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 19 Mar 2026, 07:44.

Change

Previous filing in this sequence was filed on 28 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001944721 Primary reporting owner

Ben-Tzvi Avraham

Relationship: Director
Address: BLACK TITAN CORP # 8-02 THE BOUSTEADOR,, 10 JALAN PJU 7/6, MUTIARA DAMANSARA,, SELANGOR DARUL EHSAN, MALAYSIA
Signature: /s/ Avraham Ben-Tzvi
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BTTC holding

Ordinary Shares $0.001 par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,313
Date: 01 Oct 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BTTC holding Derivative

Options to purchase Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Oct 2025
Ownership: Direct
Underlying class: See Footnote
Underlying amount: 1,250
Exercise price
Footnotes: F2

BTTC holding Derivative

Options to purchase Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Oct 2025
Ownership: Direct
Underlying class: See Footnote
Underlying amount: 5,000
Exercise price
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares were issued by Titan Pharmaceutical Inc.'s ("Titan"), and each share was exchanged for one share of Black Titan Corporation ("Black Titan") in connection with the business combination which closed on October 1, 2025 (the "Merger").

Footnote F2

Options issued pursuant to Titan's 2015 Omnibus Equity Incentive Plan with an exercise price equal to the closing price of Titan's common stock on August 15, 2022. These options were assumed by Black Titan in the Merger and exchanged for 1 Black Titan option for each Titan option.

Footnote F3

Options issued pursuant to Titan's 2015 Omnibus Equity Incentive Plan with an exercise price equal to the closing price of Titan's common stock on September 15, 2022. These options were assumed by Black Titan in the Merger and exchanged for 1 Black Titan option for each Titan option.